A company whose founders were former Amgen employees is listing shares on an exchange as part of a renewed biotech IPO wave.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company whose founders were former Amgen employees is listing shares on an exchange as part of a renewed biotech IPO wave.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Nasdaq
American fully electronic stock exchange
Related events
- Amgen Inc. trades on the NASDAQ stock exchange.
- SciSparc conducted an IPO on NASDAQ, is headquartered in Switzerland, and its information is reported via MarketBeat.
- Evelo Biosciences listed its stock on the Nasdaq exchange on August 1, 2026.
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
- Artiva Biotherapeutics stock is being traded on Nasdaq as hedge funds increase their stakes.